.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Randomized evidence supports vaginal progesterone for prevention of spontaneous preterm birth in selected women with a short cervix identified on transvaginal ultrasound. The intervention is particularly relevant because cervical shortening can precede clinically apparent preterm labor, creating an opportunity for targeted prevention. For maternal-fetal medicine practice, treatment should be based on gestational age, obstetric history and cervical-length findings rather than prescribed universally to all pregnant women. The evidence also illustrates the value of standardized cervical-length screening pathways when the population is appropriate. Clinicians should counsel patients about adherence, expected benefit and the limits of preventive therapy. Progesterone does not eliminate the need to evaluate symptoms, membrane status or other causes of preterm birth. The study fits AICOG's high-risk obstetric track because it demonstrates how ultrasound-based risk stratification can lead to a relatively simple intervention with potential to reduce prematurity and its neonatal consequences.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Randomized evidence supports vaginal progesterone for prevention of spontaneous preterm birth in selected women with a short cervix identified on transvaginal ultrasound. The intervention is particularly relevant because cervical shortening can precede clinically apparent preterm labor, creating an opportunity for targeted prevention. For maternal-fetal medicine practice, treatment should be based on gestational age, obstetric history and cervical-length findings rather than prescribed universally to all pregnant women. The evidence also illustrates the value of standardized cervical-length screening pathways when the population is appropriate. Clinicians should counsel patients about adherence, expected benefit and the limits of preventive therapy. Progesterone does not eliminate the need to evaluate symptoms, membrane status or other causes of preterm birth. The study fits AICOG's high-risk obstetric track because it demonstrates how ultrasound-based risk stratification can lead to a relatively simple intervention with potential to reduce prematurity and its neonatal consequences.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
